Insights

Washington – January 3, 2022: Crowell & Moring elected 13 lawyers to the firm’s partnership, effective January 1, 2022. The firm also promoted seven to the position of senior counsel and 19 associates to the position of counsel. The new partners have been promoted from within the ranks of the firm’s London, New York, and Washington, D.C. offices and from across several practice groups, including Advertising & Media; Antitrust & Competition; Corporate; Energy; Environment & Natural Resources; Government Contracts; Health Care; Technology & Intellectual Property; International Dispute Resolution; Litigation; Mass Tort, Product, and Consumer Litigation; and Privacy & Cybersecurity.

Washington – December 21, 2020: Crowell & Moring advised Olam International Limited (OIL) in its acquisition of the US-based chile pepper business (CPB) of Mizkan America, Inc., a major maker of condiments and sauces, for US$108.5 million. New Mexico-based CPB is one of the world’s leading suppliers of premium green chiles, jalapeños, and enchilada sauces. This acquisition, conducted through OIL’s subsidiary, Olam Americas Inc., is the first major acquisition for Olam Food Ingredients (OFI), the new operating group created after the reorganization within OIL earlier this year. The transaction is subject to US antitrust regulatory approval and customary closing conditions, which are expected to complete in January 2021

The Federal Trade Commission announced its annual updates to the thresholds and filing fees related to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the HSR Act) on Monday. These dollar thresholds are indexed annually based on changes in the U.S. gross national product and the Consumer Price Index.

This week, the Federal Trade Commission announced a massive overhaul of the Hart-Scott-Rodino (HSR) Act’s rules and instructions for premerger filings to the U.S. antitrust agencies. The proposed rule represents the most significant revisions to the HSR process since its inception in 1976, vastly expanding the scope of information required to be submitted by parties. The proposed rules would impose significant additional substantive and procedural burdens, substantially increase the time and cost to prepare filings, and raise critical strategic questions for filing parties.

On Friday, February 3, DOJ announced in a press release that it has withdrawn support for three joint DOJ-FTC policy statements that explicitly describe certain “safety zones” applicable to information sharing among competitors and the formation of certain competitor collaborations (including healthcare provider joint ventures and accountable care organizations (ACOs)) that the antitrust agencies did not intend to prosecute. See 1993 Policy Statement, 1996 Policy Statement, 2011 Accountable Care Organizations. The FTC has not yet withdrawn its support for these statements and the DOJ does not apparently plan to issue new guidance, which may result in the agencies applying differing standards and, at a minimum, creates more uncertainty about how the agencies will evaluate conduct covered by these guidance documents.